Clinical Trial Update: MC RCT - BPO vs Adapalene [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial comparing BPO to Adapalene for Molluscum Contagiosum was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Molluscum Contagiosum

Drugs mentioned

• Adapalene (Adapalene)
• BPO

Snippet

Sponsor: University of Oklahoma | Conditions: Molluscum Contagiosum | Phase 3 | Status: WITHDRAWN